Clinical Trials Browser

Interventional × Osteosarcoma × Trastuzumab × Clear all

NCT00005033 2013-06-21

Trastuzumab in Treating Patients With Recurrent Osteosarcoma

Phase 2 Completed

Sarcoma, Osteosarcoma

NCT00023998 2013-02-04

Chemotherapy With or Without Trastuzumab in Treating Patients With Metastatic Osteosarcoma

Phase 2 Completed

Osteosarcoma